Ameriprise Financial Inc Bio Sig Technologies, Inc. Transaction History

Ameriprise Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.71 - $4.35 $35,501 - $56,984	-13,100 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.94 - $4.75 $2,058 - $3,325	-700 Reduced 5.07%	13,100 $51,000
Q1 2021 May 17, 2021	SELL	$3.99 - $5.53 $829 - $1,150	-208 Reduced 1.48%	13,800 $59,000
Q4 2020 Feb 12, 2021	SELL	$2.99 - $5.79 $82,225 - $159,225	-27,500 Reduced 66.25%	14,008 $55,000
Q3 2020 Nov 16, 2020	BUY	$4.79 - $9.1 $198,823 - $377,722	41,508 New	41,508 $205,000

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $81.6M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.